Auna SA
Description
Auna S.A., a healthcare service provider, operates hospitals and clinics in Mexico, Peru, and Colombia. The company provides prepaid healthcare plans in Peru; and dental and vision plans in Mexico. The company was founded in 1989 and is based in Luxembourg, Luxembourg.
About
CEO
Mr. Jesús Zamora Leon
Employees
14,734
Instrument type
Common Stock
Sector
Healthcare
Industry
Medical Care Facilities
MIC code
XNYS
Address
46 A, Avenue JF Kennedy, Luxembourg, 1855, Luxembourg
×
Oscillators
No data available
Summary
No data available
Moving Averages
No data available
Earnings
| Date | Estimate EPS | Actual EPS | Difference | % Surprise |
|---|---|---|---|---|
| Nov 20, 2024 | 0.71 | 0.98 | 0.27 | 38.03% |
| Aug 22, 2024 | 0.57 | 0.12 | -0.45 | -78.95% |
| May 23, 2024 | 0.13 | 0.09 | -0.04 | -30.77% |
Earnings estimate
|
Next Quarter
(Mar 2025)
|
Next Year
(Dec 2025)
|
|||
|---|---|---|---|---|
| Number of analysts | — | 1 | — | 6 |
| Average estimate | — | 0.15 | — | 0.87 |
| Low estimate | — | 0.15 | — | 0.68 |
| High estimate | — | 0.15 | — | 1.09 |
| Last year EPS | — | 0.10 | — | 0.50 |
[stock_revenue_estimate]
Growth estimates
Current qtr
—
Next qtr. (Mar 2025)
58.850%
Current year
—
Next year (Dec 2025)
79.460%
Next 5 years (per annum)
—
Past 5 years (per annum)
—
Analyst Ratings
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| Sep 20, 2024 |
JP Morgan
Joseph Giordano
|
Maintains | Overweight | ▼ Lowers $14 → $13 |
| Aug 20, 2024 |
JP Morgan
Joseph Giordano
|
Maintains | Overweight | ▼ Lowers $16 → $14 |
| Apr 23, 2024 |
HSBC
Raj Sinha
|
Initiates | Buy | Announces $12.6 |
| Apr 16, 2024 |
Citigroup
Leandro Bastos
|
Initiates | Buy | Announces $14 |
| Apr 16, 2024 |
JP Morgan
Joseph Giordano
|
Initiates | Overweight | Announces $16 |
| Apr 16, 2024 |
Morgan Stanley
Mauricio Cepeda
|
Initiates | Overweight | Announces $14 |
Income statement
| 2023 | |
|---|---|
| Fiscal date | 2023-12-31 |
| Total reported revenue | 3.88B |
| Cost of revenue | 2.44B |
| Gross profit | 1.44B |
| Operating expense | |
| Research & development | — |
| Selling general and admin | 777.37M |
| Other operating expenses | — |
| Operating income | 545.73M |
| Non operating interest income | |
| Income | 16.96M |
| Expense | 535.72M |
| Other income expense | -63.40M |
| Pretax income | -124.17M |
| Tax provision | 90.17M |
| Net income | -214.34M |
| Basic EPS | -3.44 |
| Diluted EPS | -3.44 |
| Basic average shares | 274.88M |
| Diluted average shares | 274.88M |
| EBITDA | 749.68M |
| Net income from continuing op. | -214.34M |
| Minority interests | -39.58M |
| Preferred stock dividends | — |
Balance sheet
| 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|
| Fiscal date | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
| Total assets | 7.69B | 6.59B | 2.82B | 2.65B |
| Current assets | ||||
| Cash | 226.79M | 173.48M | 73.89M | 143.10M |
| Cash equivalents | 14.35M | 35.21M | 64.88M | 200.35M |
| Cash and cash equivalents | 241.13M | 208.69M | 138.77M | 343.45M |
| Other short term investments | 93.13M | — | — | — |
| Accounts receivable | 860.92M | 574.17M | 352.66M | 370.64M |
| Other receivables | — | — | — | — |
| Inventory | 130.52M | 87.58M | 61.15M | 52.57M |
| Prepaid assets | — | — | — | — |
| Restricted cash | — | — | — | — |
| Assets held for sale | — | — | — | — |
| Hedging assets | 721,000 | 69.06M | — | — |
| Other current assets | 222.73M | 255.60M | 118.68M | 69.52M |
| Non current assets | ||||
| Properties | 615.52M | 524.52M | 368.40M | 288.72M |
| Land and improvements | 412.61M | 377.19M | 250.92M | 256.14M |
| Machinery furniture equipment | 39.72M | 30.24M | 21.76M | 18.95M |
| Construction in progress | 54.85M | 24.20M | 158.29M | 131.02M |
| Leases | — | — | — | — |
| Accumulated depreciation | -487.08M | -332.07M | -264.96M | -219.48M |
| Goodwill | 5.20B | 4.56B | 694.95M | 688.60M |
| Investment properties | 6.96M | 5.98M | 1.53M | 1.60M |
| Financial assets | 81.49M | 13.54M | 144.42M | 11.71M |
| Intangible assets | 1.06B | 953.03M | 325.03M | 293.18M |
| Investments and advances | 20.87M | 13.10M | 14.29M | 12.10M |
| Other non current assets | 189.36M | 142.57M | 130.93M | 95.10M |
| Total liabilities | 5.91B | 5.04B | 2.28B | 2.00B |
| Current liabilities | ||||
| Accounts payable | 749.35M | 512.59M | 454.10M | 351.25M |
| Accrued expenses | — | — | — | — |
| Short term debt | 417.17M | 2.07B | 46.61M | 37.09M |
| Deferred revenue | 40.12M | 12.01M | 326,000 | 446,000 |
| Tax payable | 97.32M | 24.20M | 18.27M | 21.06M |
| Pensions | 120.83M | 62.96M | 56.32M | 51.59M |
| Other current liabilities | 65.38M | 44.54M | 24.68M | 11.63M |
| Non current liabilities | ||||
| Long term debt | 3.50B | 1.44B | 1.45B | 1.32B |
| Provision for risks and charges | 3.91M | 73,000 | 2.33M | 4.78M |
| Deferred liabilities | 495.83M | 470.16M | 53.57M | 51.15M |
| Derivative product liabilities | 214.16M | 183.09M | 76.57M | 57.81M |
| Other non current liabilities | — | — | — | — |
| Shareholders equity | ||||
| Common stock | 8.82M | 236.55M | 236.55M | 236.55M |
| Retained earnings | -366.90M | -90.98M | -45.49M | -12.62M |
| Other shareholders equity | 1.82B | 533.37M | -81.29M | -9.04M |
| Total shareholders equity | 1.78B | 1.56B | 545.91M | 652.07M |
| Additional paid in capital | — | 386.05M | 386.05M | 386.05M |
| Treasury stock | — | — | — | — |
| Minority interest | 311.28M | 493.08M | 50.09M | 51.14M |
Cash flow statement
| 2023 | |
|---|---|
| Operating Activities | |
| Net Income | -214.34M |
| Depreciation | 235.75M |
| Deferred Taxes | 90.17M |
| Stock-Based Compensation | 3.68M |
| Other Non-Cash Items | 707.64M |
| Accounts Receivable | -316.00M |
| Accounts Payable | — |
| Other Assets & Liabilities | -9.37M |
| Operating Cash Flow | 497.52M |
| Investing Activities | |
| Capital Expenditures | -112.05M |
| Net Intangibles | -48.92M |
| Net Acquisitions | -96.14M |
| Purchase of Investments | -22.25M |
| Sale of Investments | — |
| Investing Cash Flow | -125.67M |
| Financing Activities | |
| Long-Term Debt Issuance | 4.87B |
| Long-Term Debt Payments | -4.56B |
| Other Financing Charges | -104.41M |
| Financing Cash Flow | 196.77M |
| Other Cash Details | |
| End Cash Position | 241.13M |
| Income Tax Paid | — |
| Interest Paid | — |
| Free Cash Flow | 417.25M |
Error: Invalid format in Holders JSON file.
Article
Stock Picks From Seeking Alpha's January 2025 New Analysts
In January, Seeking Alpha welcomed 29 new analysts. This article introduces them and showcases some of their top picks. Analysts highlighted include The Conservative Investor recommending Dassault Aviation, Christopher Gray on ASML Holding, and Inflexio Research on Bragg Gaming Group, all rated as Buys. Analysts' diverse backgrounds span sectors like technology, finance, and consumer staples, with investment strategies focusing on value, growth, and special situations.
Seeking Alpha
Positive
Feb 5, 2025
Article
Auna Announces Reporting Dates for Fourth Quarter and Full-Year 2024 Financial Results
LUXEMBOURG--(BUSINESS WIRE)--Auna S.A. (NYSE: AUNA) (“Auna” or “the Company”), a leading Latin American healthcare services and plan provider with operations in Mexico, Peru and Colombia, announced today the reporting dates for its Fourth Quarter and Full-Year 2024 financial results. Earnings Release Monday, March 10, 2025 Time: After Market Close Conference Call Tuesday, March 11, 2025 Time: 8:00 a.m. ET Quiet Period Monday, February 17 through Monday, March 10, 2025 To participate, please dia.
Business Wire
Neutral
Feb 4, 2025
Article
Auna: Cheap Entry Level In Latin American Healthcare Play
Auna is a leading player in the Spanish-speaking Latin America medical industry, focusing particularly on high-complexity diseases, such as cancer. Most SSLA have a highly fragmented and underserved healthcare market, and populations are becoming elderly, demanding more and better services. AUNA stock has been impacted negatively following its IPO process, as local institutional players such as pension funds overbought the stock and had to sell due to regulatory limits.
Seeking Alpha
Neutral
Jan 15, 2025